Eileen Pruette, EVP, General Counsel at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX), bought 1,500 shares at $16.56 ($25K) on 2006-05-25, disclosed to the SEC on 2006-05-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.